Eloxx Pharmaceuticals (ELOX) Institutional Ownership → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free ELOX Stock Alerts $0.86 +0.01 (+1.18%) (As of 05/7/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for Eloxx Pharmaceuticals (NASDAQ:ELOX)CurrentInstitutional OwnershipPercentage2.90%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.32MNumber ofInstitutional Sellers(last 12 months)0 Get ELOX Insider Trade Alerts Want to know when executives and insiders are buying or selling Eloxx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ELOX Institutional Buying and Selling by Quarter Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Eloxx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2023Armistice Capital LLC275,000$1.32M0.0%N/A10.000% 2/13/2023American Financial Group Inc.37,000$67K0.0%-97.5%1.705% 2/13/2023Clal Insurance Enterprises Holdings Ltd14,626$27K0.0%-97.5%0.674% 1/26/2023 Harel Insurance Investments & Financial Services Ltd.29,410$54K0.0%-97.5%1.355% 7/25/2022Silverarc Capital Management LLC1,041,499$281K0.1%-46.6%1.202% 2/10/2022B. Riley Wealth Management Inc.48,500$34K0.0%N/A0.056% Get the Latest News and Ratings for ELOX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eloxx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/7/2022 Harel Insurance Investments & Financial Services Ltd.1,176,401$831K0.0%N/A1.364% 2/2/2022 Vanguard Capital Wealth Advisors158,900$111K0.1%-63.7%0.184% 11/17/2021Altium Capital Management LP1,118,000$1.82M0.4%+66.8%1.296% 11/16/2021Two Sigma Advisers LP705,300$1.15M0.0%+214.2%0.818% 11/16/2021Two Sigma Investments LP314,874$513K0.0%+195.7%0.365% 11/15/2021Natixis103,900$170K0.0%N/A0.120% 11/12/2021Geode Capital Management LLC772,836$1.26M0.0%+46.6%0.897% 11/9/2021Sawtooth Solutions LLC16,201$26K0.0%N/A0.019% 11/9/2021BlackRock Inc.490,871$800K0.0%+157.4%0.569% 11/1/2021 Vanguard Capital Wealth Advisors437,900$457K0.3%+250.3%0.508% 10/14/2021 Private Advisor Group LLC32,510$52K0.0%N/A0.038% 8/17/2021Millennium Management LLC393,703$783K0.0%N/A0.823% 8/17/2021Bridgeway Capital Management LLC149,000$297K0.0%-12.8%0.311% 8/16/2021LMR Partners LLP14,435$29K0.0%N/A0.030% 8/16/2021Cubist Systematic Strategies LLC83,344$166K0.0%N/A0.174% 8/16/2021Nantahala Capital Management LLC2,266,287$4.51M0.1%N/A4.736% 8/16/2021Occudo Quantitative Strategies LP42,247$84K0.0%N/A0.088% 8/16/2021Charles Schwab Investment Management Inc.367,062$731K0.0%+125.5%0.767% 8/16/2021State Street Corp189,203$377K0.0%-56.8%0.395% 8/13/2021Renaissance Technologies LLC163,900$326K0.0%N/A0.342% 8/13/2021Northern Trust Corp136,872$273K0.0%-53.2%0.286% 8/13/2021Altium Capital Management LP670,118$1.33M0.3%N/A1.400% 8/13/2021Geode Capital Management LLC527,307$1.05M0.0%+18.8%1.102% 8/13/2021Vanguard Group Inc.3,055,517$6.08M0.0%+156.2%6.385% 8/12/2021XTX Topco Ltd46,884$93K0.0%N/A0.098% 8/12/2021Ergoteles LLC121,900$243K0.0%N/A0.255% 8/11/2021Deutsche Bank AG68,000$135K0.0%+279.6%0.142% 8/9/2021Meeder Asset Management Inc.20,457$41K0.0%+242.3%0.043% 8/3/2021 Victory Capital Management Inc.12,359$25K0.0%N/A0.026% 7/28/2021 Vanguard Capital Wealth Advisors125,000$248K0.2%N/A0.261% 5/13/2021Barclays PLC22,278$74K0.0%+159.0%0.047% 5/12/2021Northern Trust Corp292,217$970K0.0%-9.3%0.611% 5/12/2021Geode Capital Management LLC443,810$1.47M0.0%+5.7%0.927% 5/7/2021BlackRock Inc.1,529,325$5.08M0.0%+1.7%3.803% While traders were studying charts, I was placing THIS trade (Ad)Let me show you an example of how my $0.25 Cent Trades could work with an example from back in January this year, okay? Now if you were looking at the charts… The S&P 500 was officially out of the bear market and roaring higher… By mid-January we were at new highs… And folks were left guessing if the breakout would continue or if we would make a natural pullback.Click now to see for yourself what $0.25 Cent Trades is all about2/19/2021JPMorgan Chase & Co.69,725$278K0.0%+599.8%0.174% 2/16/2021Charles Schwab Investment Management Inc.162,804$648K0.0%+4.3%0.405% 2/11/2021Northern Trust Corp322,099$1.28M0.0%-0.8%0.802% 2/11/2021Barclays PLC8,601$34K0.0%-29.1%0.021% 2/10/2021Rhumbline Advisers33,364$133K0.0%+20.0%0.083% 2/10/2021Renaissance Technologies LLC39,733$158K0.0%-33.3%0.099% 2/9/2021Wells Fargo & Company MN37,814$151K0.0%+31.2%0.094% 2/9/2021 Bank of New York Mellon Corp71,568$285K0.0%-4.5%0.178% 2/5/2021BlackRock Inc.1,503,924$5.99M0.0%+0.6%3.745% 11/10/2020State Street Corp445,336$1.17M0.0%+2.8%1.110% 11/6/2020BlackRock Inc.1,494,861$3.93M0.0%-1.1%3.724% 8/31/2020Bridgeway Capital Management Inc.175,800$533K0.0%+83.3%0.438% 8/20/2020Charles Schwab Investment Management Inc.156,295$474K0.0%+2.9%0.389% 8/12/2020 Bank of New York Mellon Corp64,842$196K0.0%-5.5%0.162% 8/7/2020State Board of Administration of Florida Retirement System15,010$44K0.0%N/A0.037% 5/15/2020Squarepoint Ops LLC51,100$100K0.0%-19.8%0.127% 5/15/2020Morgan Stanley74,740$147K0.0%-55.3%0.186% 5/15/2020DAFNA Capital Management LLC191,494$375K0.2%-7.0%0.477% 5/14/2020Wells Fargo & Company MN22,983$45K0.0%-28.0%0.057% 5/14/2020Geode Capital Management LLC385,261$755K0.0%+11.3%0.960% 5/14/2020Nuveen Asset Management LLC117,080$230K0.0%+21.9%0.292% 5/12/2020Altshuler Shaham Ltd1,141,122$2.24M0.1%+4.2%2.844% 5/1/2020BlackRock Inc.1,414,465$2.77M0.0%-1.8%3.525% 5/1/2020UBS Group AG14,641$29K0.0%-55.6%0.036% (Data available from 1/1/2016 forward) ELOX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ELOX shares? During the previous two years, the following institutional investors and hedge funds held shares of Eloxx Pharmaceuticals shares: Armistice Capital LLC ($1.32M), Silverarc Capital Management LLC ($281K), American Financial Group Inc. ($67K), and Harel Insurance Investments & Financial Services Ltd. ($54K), Clal Insurance Enterprises Holdings Ltd ($27K).Learn more on ELOX's institutional investors. What percentage of Eloxx Pharmaceuticals stock is owned by institutional investors? 2.90% of Eloxx Pharmaceuticals stock is owned by institutional investors. Learn more on ELOX's institutional investor holdings. Which institutional investors have been buying Eloxx Pharmaceuticals stock? The following institutional investors have purchased Eloxx Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($275K). How much institutional buying is happening at Eloxx Pharmaceuticals? Institutional investors have bought a total of 275,000 shares in the last 24 months. This purchase volume represents approximately $1.32M in transactions. Which Eloxx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Eloxx Pharmaceuticals stock in the last 24 months: American Financial Group Inc. ($1.44M), Harel Insurance Investments & Financial Services Ltd. ($1.15M), Silverarc Capital Management LLC ($909.45K), and Clal Insurance Enterprises Holdings Ltd ($570.37K). How much institutional selling is happening at Eloxx Pharmaceuticals? Institutional investors have sold a total of 4,069,815 shares in the last 24 months. This volume of shares sold represents approximately $5.99M in transactions. Related Companies: Windtree Therapeutics Institutional Ownership Finch Therapeutics Group Institutional Ownership TC Biopharm Institutional Ownership Acorda Therapeutics Institutional Ownership Creative Medical Technology Institutional Ownership Inhibikase Therapeutics Institutional Ownership BioCardia Institutional Ownership Genetic Technologies Institutional Ownership Agile Therapeutics Institutional Ownership Eiger BioPharmaceuticals Institutional Ownership This page (NASDAQ:ELOX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsUrgent Nvidia WarningAltimetryForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eloxx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.